Brenda Hines, MD
Sleep Medicine · Flowood, MSNPI 1932296589
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,558 of the $56,432 with a category attached, or 75.4%. Idorsia Pharmaceuticals US Inc accounts for 65.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $27,417 and has fallen 99.6% since, to $106 in 2025.
Across 388 payments — averaging $145.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Idorsia Pharmaceuticals US Inc$37K
- Eisai Inc.$7K
- Jazz Pharmaceuticals Inc.$5K
- Inspire Medical Systems, Inc.$3K
- Harmony Biosciences LLC$2K
- Axsome Therapeutics, Inc.$533
- plus $1K from 10 others
What the payments were for
- Consulting fees$1,8913%
- Speaking & faculty fees$42,55875%
- Travel & lodging$2,4404%
- Food & beverage$9,43217%
- Education$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Idorsia Pharmaceuticals US Inc | 52 | $37,062 |
| Eisai Inc. | 32 | $7,477 |
| Jazz Pharmaceuticals Inc. | 118 | $5,484 |
| Inspire Medical Systems, Inc. | 44 | $3,202 |
| Harmony Biosciences LLC | 75 | $1,568 |
| Axsome Therapeutics, Inc. | 19 | $533 |
| Avadel CNS Pharmaceuticals, LLC | 12 | $373 |
| Merck | 17 | $320 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $158 |
| Vanda Pharmaceuticals Inc. | 1 | $71 |
| Arbor Pharmaceuticals, Inc. | 3 | $55 |
| Itamar Medical Inc | 3 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Tris Pharma Inc | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few sleep medicine providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Oxybate | 19 | $360,910 |
| XywavSodium,calcium,mag,pot Oxybate | 16 | $288,026 |
| WakixPitolisant Hcl | 15 | $216,515 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 58 | $1,515 |
| Trazodone Hcl | 65 | $801 |
| Duloxetine Hcl | 45 | $595 |
| Aripiprazole | 16 | $535 |
| Mirtazapine | 37 | $514 |
| Clonazepam | 96 | $453 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $383 |
| Quetiapine Fumarate | 37 | $349 |
| Zaleplon | 27 | $321 |
| Bupropion XlBupropion Hcl | 14 | $290 |
| Escitalopram Oxalate | 24 | $268 |
| Ropinirole Hcl | 25 | $267 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $1,568 | $216,51515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few sleep medicine providers in Mississippion file to place this against a meaningful peer group, so we don't.
Other sleep medicine in Flowood
- Andrea LewisJackson$36K
- Christopher KarcherOcean Springs$26K
- John DouglasGulfport$8K
- Gowdhami MohanClarksdale$5K
- Sanjay RatnakantSouthaven$2K
- John BoswellColumbus$2K
- Kary WhiteheadMeridian$2K
- Mohammad UllahJackson$2K
- Alexandra EdwardsLaurel$1K
- Dani ChoufaniJackson$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.